Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

The proportion of adolescents living with overweight and obesity in England increased by 50% over 15 years, and many related ...

Investing.com -- Shares of Hims & Hers Health, Inc. (NYSE: HIMS) climbed 30% following the announcement of a long-term collaboration with Novo Nordisk (NYSE: NVO) to enhance obesity care. The ...

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity. Consumers will now be able to access ...

Novo Nordisk and Hims & Hers Health, Inc. (NYSE: HIMS) today announced a long-term collaboration designed to make proven ...

The US Food and Drug Administration seized fake Ozempic injections. This happened on April 9, 2025. Novo Nordisk warned about ...

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...